Cargando…
USP53 Exerts Tumor-Promoting Effects in Triple-Negative Breast Cancer by Deubiquitinating CRKL
SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) has a high recurrence rate and metastasis rate, and the prognosis for patients is poor. Identifying novel treatment avenues for TNBC is crucial for the treatment and prognosis of TNBC patients. Deubiquitinase deficiency is associated with the occu...
Autores principales: | Liu, Yi, Tang, Wei, Yao, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605207/ https://www.ncbi.nlm.nih.gov/pubmed/37894400 http://dx.doi.org/10.3390/cancers15205033 |
Ejemplares similares
-
USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
por: Lin, Yueh-Te, et al.
Publicado: (2022) -
USP47 Promotes Tumorigenesis by Negative Regulation of p53 through Deubiquitinating Ribosomal Protein S2
por: Cho, Jinhong, et al.
Publicado: (2020) -
Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency
por: Ma, Yu-Shui, et al.
Publicado: (2020) -
USP13 negatively regulates antiviral responses by deubiquitinating STING
por: Sun, He, et al.
Publicado: (2017) -
Deubiquitination and stabilization of PTEN by USP13
por: Zhang, Jinsong, et al.
Publicado: (2013)